These patients require frequent observation for neurological signs and symptoms of spinal or epidural haematoma. Concomitant use not recommended Tacrolimus Tacrolimus has been found in vitro to have a similar level of inhibitory effect on P-gp as that seen with itraconazole and cyclosporine.
International non-proprietary name INN or common name. There was no influence on male fertility. In young healthy male volunteers, the concomitant administration of dabigatran etexilate and clopidogrel dabigatra in no further prolongation of capillary bleeding times compared to clopidogrel monotherapy. Concomitant administration of 90 mg ticagrelor b. If treatment is not started on the day of surgery then treatment should be initiated with 2 capsules once daily.
Half-life of total dabigatran in healthy subjects and subjects with impaired renal function. Show table of contents Hide table of contents 1.
For further information, see the summary of product characteristics also part of the EPAR. In vitro interaction studies did not show any inhibition or induction of the principal isoenzymes of cytochrome P For the primary safety endpoint of major bleeding there was an interaction of treatment effect and age.
P-gp substrate Digoxin In a study performed with 24 healthy subjects, when Pradaxa was co-administered with digoxin, no changes on digoxin and no clinically relevant changes on dabigatran exposure have been observed. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more of the following risk factors: Patients with gastritis, esophagitis or gastroesophageal reflux.
Although the studies showed a small higher risk of heart problems with Dbaigatran than with warfarin, the benefits of Pradaxa were dabiggatran considered to outweigh its risks. Concomitant administration of a loading dose of mg ticagrelor and mg dabigatran etexilate in steady state increased the dabigatran AUC ,ss and C max,ss by 1. Bleeding can occur at any site during therapy with Pradaxa. Musculoskeletal and connective tissue disorders.
This website uses cookies to improve your experience while you navigate through the website. Initial U. Other referenced trademarks are owned by third parties. Dabigatran etexilate was given twice daily over 3 consecutive days, on the 3 rd day either with or without quinidine. Pradaxa mg psc daily Warfarin Hazard ratio vs.
Pradaxa mg hard capsules. It explains how the Committee for Medicinal Products for Human Use CHMP assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Pradaxa.
Peak plasma concentrations are reached at 6 hours following administration in a postoperative period due to contributing factors such as anaesthesia, gastrointestinal paresis, and surgical effects independent of the oral medicinal product formulation.
If surgery cannot be delayed the risk of bleeding may be increased. Pradaxa must sabigatran not be used in patients with serious liver problems or patients taking by mouth or injection the medicines ketoconazole and itraconazole used for fungal infectionsciclosporin a xpc used to reduce the activity of the immune system or dronedarone a medicine to treat a heart problem called atrial fibrillation. Clearance of dabigatran by haemodialysis was investigated in 7 patients with end-stage renal disease ESRD without atrial fibrillation.
Find out more here. No clinically relevant inter-ethnic differences among Caucasian, African-American, Hispanic, Japanese or Chinese patients were observed regarding dabigatran pharmacokinetics and pharmacodynamics. Half-life of total dqbigatran in healthy subjects and subjects with impaired renal function.
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more of the following risk factors:. Known bleeding complications such as compartment syndrome and acute renal failure due to hypoperfusion have been reported for Pradaxa. The dabigatran AUC and C max were increased by about 1. From 6 hours prior to the next scheduled dose on, the missed dose should be omitted.
Pharmacodynamic interactions see section 4. All bleeding events which occurred dabigagran warfarin therapy are dabogatran except for those during the overlap period between warfarin and parenteral therapy. Dabigatran is an anticoagulant, meaning that it prevents the blood from coagulating clotting. Table 3 shows coagulation test thresholds at trough that may be associated dabigartan an increased risk of bleeding see section 5. After multiple doses of ticagrelor 90 mg b.
Dabigatran etexilate was given twice daily over 3 consecutive days, on the 3 rd day either with or without quinidine. Concomitant administration of P-gp inhibitors see table 6 is expected to result in increased dabigatran plasma concentrations. Although high aPTT values should be interpreted with caution, a high aPTT value indicates that the patient is anticoagulated. This staggered intake is the recommended administration for start of ticagrelor with a loading dose.
Dabigatran inhibits free thrombin, fibrin-bound thrombin and thrombin-induced platelet aggregation. By continuing to browse the site you are agreeing to our policy on the use of cookies. Elimination Plasma concentrations of dabigatran showed a biexponential decline with a mean terminal half-life of 11 hours in healthy elderly subjects. Biotransformation Metabolism and excretion of dabigatran were studied following a single intravenous dose of radiolabeled dabigatran in healthy male subjects.
Particular caution should be exercised when Pradaxa is co-administered with verapamil, amiodarone, quinidine or clarithromycin P-gp inhibitors and particularly in the occurrence of bleeding, notably in patients having a mild to moderate renal impairment see section 4. Pre-dosing of the probe inducer rifampicin at a dose of mg once daily for 7 days decreased total dabigatran peak and total exposure by After oral administration of Pradaxa in healthy volunteers, the pharmacokinetic profile of dabigatran in plasma is characterized by a rapid increase in plasma concentrations with C max attained within 0.
0コメント